# BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects

> **NCT01964131** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 34 (actual)

## Conditions studied

- Gastric Ulcer
- Duodenal Ulcer
- Anastomotic Ulcer
- Reflux Esophagitis
- Etc.

## Interventions

- **DRUG:** D961H sachet 20 mg
- **DRUG:** D961H HPMC capsule 20 mg

## Key facts

- **NCT ID:** NCT01964131
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964131, "BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01964131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*